The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 31, 2020

Filed:

Mar. 25, 2016
Applicant:

Igm Biosciences, Inc., Mountain View, CA (US);

Inventors:

Stephen F. Carroll, Walnut Creek, CA (US);

Ramesh Baliga, Redwood City, CA (US);

Dean Ng, San Francisco, CA (US);

Bruce Keyt, Hillsborough, CA (US);

Assignee:

IGM Biosciences, Inc., Mountain View, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/08 (2006.01); C07K 16/28 (2006.01); A61K 39/395 (2006.01); A61K 39/40 (2006.01); A61P 1/16 (2006.01); A61P 31/20 (2006.01); G01N 33/50 (2006.01); G01N 33/569 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/082 (2013.01); A61K 39/395 (2013.01); A61K 39/39541 (2013.01); A61K 39/40 (2013.01); A61P 1/16 (2018.01); A61P 31/20 (2018.01); C07K 16/2809 (2013.01); G01N 33/502 (2013.01); G01N 33/56983 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/31 (2013.01); C07K 2317/35 (2013.01); C07K 2317/56 (2013.01); C07K 2317/60 (2013.01); C07K 2317/622 (2013.01); C07K 2317/734 (2013.01); C07K 2317/76 (2013.01); G01N 2333/02 (2013.01); G01N 2500/04 (2013.01); G01N 2500/10 (2013.01);
Abstract

This disclosure provides a multimeric hepatitis B virus (HBV) protein binding molecule, e.g., a dimeric IgA or a pentameric or hexameric IgM binding molecule, comprising at least two bivalent binding units, or variants or fragments thereof, each comprising at least two antibody heavy chain constant regions or fragments thereof, wherein each heavy chain constant region or fragment thereof is associated with an HBV antigen binding domain. The disclosure also provides compositions comprising the multimeric binding molecules, polynucleotides encoding the multimeric binding molecules, and methods to make and use the multimeric binding molecules.


Find Patent Forward Citations

Loading…